Status:
COMPLETED
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Observational, short-term prospective, multicenter study to assess psychometric properties of the Spanish version of SWN-K scale in patients with schizophrenia.
Eligibility Criteria
Inclusion
- Patients with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder (DSM-IV TR criteria)
- Stabilized out-patients
- Under treatment with an oral antipsychotic drug
Exclusion
- Administration of a depot antipsychotic drug
- Participation in another clinical trial within 4 weeks prior to enrolment into this study
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00749970
Start Date
July 1 2008
End Date
January 1 2009
Last Update
December 10 2010
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alicante, Spain
2
Research site
Barcelona, Spain
3
Research site
Burgos, Spain
4
Research Site
Córdoba, Spain